2010 annual financial data
Supernus Pharmaceuticals 2010 Operating margin
Supernus Pharmaceuticals 2010 operating margin with verified reported values.
Direct answer
Operating margin was -37,851.89%.
Operating income was -40,123,000 USD and net income was -38,463,000 USD.
Operating cash flow was -32,544,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 106,000 USD
- Operating income
- -40,123,000 USD
- Net income
- -38,463,000 USD
- Operating cash flow
- -32,544,000 USD